Skip to content

An Investigation of Early Life Stress and Depression

Early Life Stress and Depression: Molecular and Functional Imaging Approaches

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01701258
Enrollment
153
Registered
2012-10-05
Start date
2013-08-31
Completion date
2017-05-31
Last updated
2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

History of Childhood Sexual Abuse (CSA), Major Depressive Disorder (MDD)

Keywords

Depression, Childhood Sexual Abuse, Dopamine, MRI, PET, ERP, Stress, Reward, Childhood trauma, Amisulpride

Brief summary

The purpose of this study is to investigate brain pathways within adult females (with a history of CSA that occurred between the ages of 5-14) with and without a current diagnosis of major depressive disorder (MDD). Hypotheses: The CSA/MDD participants will be characterized by (1) reduced reward responsiveness and prefrontal cortex activity, but increased cortisol levels, (2) reduced dopamine activity, and (3) reduced dopamine transporter binding. The over-arching purpose of the study is to (1) identify individuals at risk for psychopathology and maladaptive behavior, (2) prevent re-victimization, and (3) develop more targeted therapeutic interventions.

Detailed description

This study will include four sessions: Session 1 (SCID Session) The first session takes place at the Center for Depression, Anxiety, and Stress Research (CDASR) or Neuroimaging Center (both at McLean Hospital) and involves consenting, a clinical evaluation, a series of questionnaires, and a medical assessment. Session 2 or 3 (fMRI Session) The third session takes place at the Neuroimaging Center. Using a double-blind design, participants will be administered either amisulpride (50 mg) or placebo. Participants will complete the Monetary Incentive Delay (MID) task during functional magnetic resonance imaging (fMRI) and the Probabilistic Stimulus Selection Task (PSST) afterwards. Session 2 or 3 (PET Session) This session takes place at Massachusetts General Hospital. 9 mCi of \[11C\] altropane will be injected by a trained nuclear medicine technician and positron emission tomography (PET) scanning will begin. Prior to the PET scan, a blood serum pregnancy test will be administered for females. Session 4 (ERP Session) The fourth session takes place at the CDASR and involves an electroencephalography (EEG) recording, the Probabilistic Reward Task (PRT), and collecting saliva samples to assess cortisol levels.

Interventions

DRUGAmisulpride

single low-dose pharmacological challenge, 50 mg amisulpride during the fMRI session only

DRUGPlacebo

single-dose placebo capsule during the fMRI session only

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Massachusetts General Hospital
CollaboratorOTHER
Mclean Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Intervention model description

There were four groups of subjects: those with a history of child sexual abuse that are currently experiencing a major depressive episode, those with a history of child sexual abuse without a current or past diagnosis of major depressive disorder, those without a history of child sexual abuse that are currently experiencing a major depressive episode, and those with without a history of child sexual abuse and without a current or past diagnosis of major depressive disorder. Within each group, half of the subjects were assigned to receive the study drug (amisulpride) and half to receive a placebo for the fMRI session (session 2 or 3).

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

General Inclusion Criteria: * Females of all ethnic origins, age between 20 and 45; right-handed (Chapman & Chapman 1987); * Absence of any psychotropic medications for at least 2 weeks (6 weeks for fluoxetine; 6 months for neuroleptics; 2 weeks for benzodiazepines; 2 weeks for any other antidepressants); Inclusion Criteria for Childhood Sexual Abuse/MDD (CSA/MDD) Group: * At least one incident of contact sexual abuse1 between the ages 5-14 years; * Current DSM-IV diagnostic criteria for MDD (as diagnosed with the use of the SCID); Inclusion Criteria for Childhood Sexual Abuse/Resilient (CSA/RES) Group: * At least one incident of contact sexual abuse1 between the ages 5-14 years; * Absence of past or current DSM diagnosis, including MDD or alcohol/substance abuse; Inclusion Criteria for Non-traumatized, MDD (MDD) Group: * No incidents of sexual, verbal, or physical abuse (ascertained using the Traumatic Antecedents Questionnaire); * Current DSM-IV diagnostic criteria for MDD (as diagnosed with the use of SCID); Non-traumatized, healthy controls (controls): * No incidents of sexual, verbal, or physical abuse (ascertained using the Traumatic Antecedents Questionnaire); * Absence of any medical, neurological, and psychiatric illness (including alcohol/substance abuse)

Exclusion criteria

* Participants with suicidal ideation where study participation is deemed unsafe by the study clinician; * Pregnant women or women of childbearing potential who are not compliant with the requirements of a urine and blood pregnancy test. * Failure to meet MRI or PET safety requirements. * Serious or unstable medical illness, including cardiovascular, hepatic, renal, respiratory, endocrine (hypothyroidism), neurologic or hematologic disease; * Past/current DSM diagnosis of: OCD, ADHD, schizophrenia, schizoaffective disorder, delusional disorder, bipolar disorder, mood congruent/incongruent psychotic features, substance dependence, substance abuse within the last 12 months (with the exception of cocaine or stimulant abuse, which will lead to automatic exclusion); * Simple phobia, social anxiety disorder and generalized anxiety disorders will be allowed only if secondary to MDD and only in the CSA/MDD and MDD groups (which will be matched for comorbidities); * History of seizure disorder; renal insufficiency; history of adverse reactions to amisulpride; * History of cocaine, stimulant, and other DA drug use \[e.g., (meth)amphetamine), methylphenidate\].

Design outcomes

Primary

MeasureTime frameDescription
Dopamine Active Transporter Binding Potential1 hour PET scan (Session 3)Utilizing 11C-altropane during positron emission tomography (PET) scanning allows us to measure dopamine active transporter (DAT) binding potential. Our outcome measure is Nondisplacable Binding Potential (BPND). BPND refers to the ratio at equilibrium of specifically bound radioligand to that of nondisplaceable radioligand in tissue. \*Higher BPND scores indicate greater binding potential
The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress3 hour EEG Session (Session 4)The participant's performance on the Probabilistic Reward Task (PRT) was assessed both before and after an acute stressor. The PRT is a behavioral task that measures an individual's ability to learn from rewarding stimuli and incorporate this learning into their response style (response bias). The acute stressor was the Maastricht Acute Stress Test (MAST). The score obtained is a ratio of the number of times participants correctly choose the high reward stimuli versus the low rewarding stimuli. Response bias scores range between -1 and +1. Higher response bias scores indicate a stronger response bias toward high reward stimuli. A negative response bias indicates a stronger bias toward low reward stimuli.
The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress3 hour EEG Session (Session 4)EEG was recorded during the probabilistic reward task (the PRT task). Participants completed the Probabilistic Reward Task (PRT) twice throughout the experiment, once before stress and once after stress. The stressor was the Maastricht Acute Stress Test (MAST). This statistic shows the effect that childhood sexual abuse (CSA) and diagnosis had on a reward-related positivity EEG component recorded during the PRT, before and after stress. * Higher reward positivity amplitudes indicate a stronger neural response to reward and lower amplitudes indicate a lower neural response to rewards.
Cortisol Output in Response to a Stress Manipulation3 hour EEG Session (Session 4)This statistic shows the impact of the stress manipulation on the participant's salivary cortisol output. Saliva samples were collected at 5 distinct time points throughout the study session. The first saliva sample (Cort 1) was collected when the participant began the eeg session. The second (Cort 2)was taken at the end of the acute stressor. The third (Cort 3) was taken approximately fifteen minutes after the second. The fourth (Cort 4) was taken approximately ten minutes after the third. The fifth (Cort 5) was taken approximately 40 minutes after the fourth.
Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues3 hour Drug & fMRI Session (Session 2)This statistic shows the influence of major depressive disorder and childhood sexual abuse history on the strength of striatal activation (caudate, putamen, accumbens) in response to neutral and reward cues during the monetary incentive delay task (MID). Striatal activation is measured using a statistic called a beta weight. A beta weight is a standardized regression coefficient. Higher beta weights mean greater striatal activation and lower beta weights mean less striatal activation. A negative beta weight would indicate a deactivation.
Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback3 hour Session 2 (fMRI session)This statistic shows the influence of major depressive disorder and childhood sexual abuse history on the strength of striatal activation (caudate, putamen, accumbens) in response to neutral and reward feedback during the monetary incentive delay task (MID). Striatal activation is measured using a statistic called a beta weight. A beta weight is a standardized regression coefficient. Higher beta weights mean greater striatal activation and lower beta weights mean less striatal activation. A negative beta weight would indicate a deactivation.
The Effect of Diagnosis on Cortisol Reactivity3 hour EEG Session (Session 4)This is a measure of area under the curve in relation to ground, a measure of total cortisol output, in response to acute stress. The acute stressor was the Maastricht Acute Stress Test (MAST). The area under the curve includes all 5 cortisol measures, with one measure before the stressor and the other four measures collected after the stressor. Given that the cortisol data were positively skewed, the cortisol measures were normalized via a log transformation prior to calculating the area under the curve. Area under the curve with respect to ground (AUCG) is calculated AUC\_g=(((cort2\_log + cort1\_log) \* cort\_t1\_time) / 2)+(((cort3\_log+cort2\_log)\*cort\_t2\_time)/2)+(((cort4\_log+cort3\_log)\*cort\_t3\_time)/2)+(((cort5\_log+cort4\_log)\*cort\_t4\_time)/2). Cort\_logs are the log transformed cortisol output data (ng/ml) and the cort\_times are the time spans in between each cortisol assessment.

Countries

United States

Participant flow

Recruitment details

Participants were recruited at McLean Hospital (Belmont, MA) between August, 2013, and June, 2017. The study was advertised using flyers, and on a number of internet bulletin boards available to the general public. Study visits were conducted in research facilities at McLean Hospital and Massachusetts General Hospital.

Pre-assignment details

In session 1, subjects had a diagnostic interview, a physical exam, provided a blood sample, and completed surveys, to determine eligibility. Those eligible were invited to participate in the other sessions. Participants did not need to complete all sessions. The order depended on facility availability and convenience for participants.

Participants by arm

ArmCount
Control Group
Subjects without a history of child sexual abuse and without a current or past diagnosis of major depressive episode.
26
MDD Group
Subjects without a history of child sexual abuse that are currently experiencing a major depressive episode are randomized to receive a single low-dose pharmacological challenge.
17
CSA/RES Group
Subjects with a history of CSA but no psychopathology (resilient group; CSA/RES).
24
CSA/MDD Group
Subjects experiencing a current episode of major depression (MDD) with a history of child sexual abuse (CSA) are randomized to receive a single low-dose pharmacological challenge.
29
Total96

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005FG006FG007FG008FG009FG010FG011FG012
Assessment and SchedulingFound to be Ineligible57000000000000
Assessment and SchedulingInvestigator Terminated2000000000000
Assessment and SchedulingLost to Follow-up10000000000000
Assessment and SchedulingWithdrawal by Subject14000000000000

Baseline characteristics

CharacteristicControl GroupMDD GroupCSA/RES GroupCSA/MDD GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
26 Participants17 Participants24 Participants29 Participants96 Participants
Age, Continuous22.44 years
STANDARD_DEVIATION 6.64
27.19 years
STANDARD_DEVIATION 5.99
25.61 years
STANDARD_DEVIATION 4.94
29.95 years
STANDARD_DEVIATION 6.91
26.63 years
STANDARD_DEVIATION 6.08
BDI II1.68 units on a scale
STANDARD_DEVIATION 2.79
27.23 units on a scale
STANDARD_DEVIATION 8.44
3.83 units on a scale
STANDARD_DEVIATION 5.77
31.49 units on a scale
STANDARD_DEVIATION 9.05
15.95 units on a scale
STANDARD_DEVIATION 15.14
MASQ total93.04 units on a scale
STANDARD_DEVIATION 16.27
167.86 units on a scale
STANDARD_DEVIATION 22.6
101.82 units on a scale
STANDARD_DEVIATION 26.19
180.57 units on a scale
STANDARD_DEVIATION 21.89
135.42 units on a scale
STANDARD_DEVIATION 44.65
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
2 Participants2 Participants0 Participants4 Participants8 Participants
Race (NIH/OMB)
Black or African American
3 Participants4 Participants9 Participants5 Participants21 Participants
Race (NIH/OMB)
More than one race
2 Participants0 Participants1 Participants5 Participants8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants2 Participants2 Participants
Race (NIH/OMB)
White
18 Participants11 Participants14 Participants13 Participants56 Participants
Region of Enrollment
United States
26 Participants17 Participants24 Participants29 Participants96 Participants
Sex: Female, Male
Female
26 Participants17 Participants24 Participants29 Participants96 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
EG008
affected / at risk
EG009
affected / at risk
EG010
affected / at risk
EG011
affected / at risk
EG012
affected / at risk
EG013
affected / at risk
deaths
Total, all-cause mortality
0 / 1530 / 960 / 260 / 110 / 110 / 170 / 90 / 80 / 240 / 60 / 60 / 290 / 100 / 7
other
Total, other adverse events
0 / 1530 / 960 / 260 / 110 / 110 / 170 / 90 / 80 / 240 / 60 / 60 / 290 / 100 / 7
serious
Total, serious adverse events
0 / 1530 / 960 / 260 / 110 / 110 / 170 / 90 / 80 / 240 / 60 / 60 / 290 / 100 / 7

Outcome results

Primary

Cortisol Output in Response to a Stress Manipulation

This statistic shows the impact of the stress manipulation on the participant's salivary cortisol output. Saliva samples were collected at 5 distinct time points throughout the study session. The first saliva sample (Cort 1) was collected when the participant began the eeg session. The second (Cort 2)was taken at the end of the acute stressor. The third (Cort 3) was taken approximately fifteen minutes after the second. The fourth (Cort 4) was taken approximately ten minutes after the third. The fifth (Cort 5) was taken approximately 40 minutes after the fourth.

Time frame: 3 hour EEG Session (Session 4)

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupCortisol Output in Response to a Stress ManipulationCort412.89 ng/mlStandard Error 4.07
Control GroupCortisol Output in Response to a Stress ManipulationCort29.11 ng/mlStandard Error 2.44
Control GroupCortisol Output in Response to a Stress ManipulationCort57.07 ng/mlStandard Error 1.8
Control GroupCortisol Output in Response to a Stress ManipulationCort315.55 ng/mlStandard Error 4.91
Control GroupCortisol Output in Response to a Stress ManipulationCort19.80 ng/mlStandard Error 1.27
MDD GroupCortisol Output in Response to a Stress ManipulationCort315.23 ng/mlStandard Error 1.65
MDD GroupCortisol Output in Response to a Stress ManipulationCort416.30 ng/mlStandard Error 3.24
MDD GroupCortisol Output in Response to a Stress ManipulationCort510.34 ng/mlStandard Error 1.15
MDD GroupCortisol Output in Response to a Stress ManipulationCort212.28 ng/mlStandard Error 1.7
MDD GroupCortisol Output in Response to a Stress ManipulationCort112.53 ng/mlStandard Error 2.11
CSA/RES GroupCortisol Output in Response to a Stress ManipulationCort310.75 ng/mlStandard Error 2.19
CSA/RES GroupCortisol Output in Response to a Stress ManipulationCort110.15 ng/mlStandard Error 2.27
CSA/RES GroupCortisol Output in Response to a Stress ManipulationCort29.51 ng/mlStandard Error 1.89
CSA/RES GroupCortisol Output in Response to a Stress ManipulationCort48.99 ng/mlStandard Error 1.75
CSA/RES GroupCortisol Output in Response to a Stress ManipulationCort57.41 ng/mlStandard Error 1.36
CSA/MDD GroupCortisol Output in Response to a Stress ManipulationCort414.22 ng/mlStandard Error 2.74
CSA/MDD GroupCortisol Output in Response to a Stress ManipulationCort28.63 ng/mlStandard Error 0.95
CSA/MDD GroupCortisol Output in Response to a Stress ManipulationCort114.19 ng/mlStandard Error 1.51
CSA/MDD GroupCortisol Output in Response to a Stress ManipulationCort314.31 ng/mlStandard Error 2.15
CSA/MDD GroupCortisol Output in Response to a Stress ManipulationCort511.01 ng/mlStandard Error 2.15
Primary

Dopamine Active Transporter Binding Potential

Utilizing 11C-altropane during positron emission tomography (PET) scanning allows us to measure dopamine active transporter (DAT) binding potential. Our outcome measure is Nondisplacable Binding Potential (BPND). BPND refers to the ratio at equilibrium of specifically bound radioligand to that of nondisplaceable radioligand in tissue. \*Higher BPND scores indicate greater binding potential

Time frame: 1 hour PET scan (Session 3)

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupDopamine Active Transporter Binding PotentialCaudate3.191 RatioStandard Error 0.124
Control GroupDopamine Active Transporter Binding PotentialAccumbens2.159 RatioStandard Error 0.109
Control GroupDopamine Active Transporter Binding PotentialPutamen3.361 RatioStandard Error 0.12
MDD GroupDopamine Active Transporter Binding PotentialAccumbens2.103 RatioStandard Error 0.122
MDD GroupDopamine Active Transporter Binding PotentialCaudate3.161 RatioStandard Error 0.139
MDD GroupDopamine Active Transporter Binding PotentialPutamen3.359 RatioStandard Error 0.134
CSA/RES GroupDopamine Active Transporter Binding PotentialPutamen3.241 RatioStandard Error 0.125
CSA/RES GroupDopamine Active Transporter Binding PotentialAccumbens2.103 RatioStandard Error 0.122
CSA/RES GroupDopamine Active Transporter Binding PotentialCaudate3.175 RatioStandard Error 0.13
CSA/MDD GroupDopamine Active Transporter Binding PotentialAccumbens2.149 RatioStandard Error 0.119
CSA/MDD GroupDopamine Active Transporter Binding PotentialPutamen3.318 RatioStandard Error 0.131
CSA/MDD GroupDopamine Active Transporter Binding PotentialCaudate3.216 RatioStandard Error 0.136
Primary

Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Cues

This statistic shows the influence of major depressive disorder and childhood sexual abuse history on the strength of striatal activation (caudate, putamen, accumbens) in response to neutral and reward cues during the monetary incentive delay task (MID). Striatal activation is measured using a statistic called a beta weight. A beta weight is a standardized regression coefficient. Higher beta weights mean greater striatal activation and lower beta weights mean less striatal activation. A negative beta weight would indicate a deactivation.

Time frame: 3 hour Drug & fMRI Session (Session 2)

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Neutral Cues.385 beta weight (slope)Standard Error 0.173
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Reward Cues.514 beta weight (slope)Standard Error 0.199
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Neutral Cues.254 beta weight (slope)Standard Error 0.161
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Reward Cues.550 beta weight (slope)Standard Error 0.175
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Reward Cues.692 beta weight (slope)Standard Error 0.206
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Neutral Cues.550 beta weight (slope)Standard Error 0.175
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Reward Cues.468 beta weight (slope)Standard Error 0.209
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Reward Cues.054 beta weight (slope)Standard Error 0.238
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Neutral Cues.357 beta weight (slope)Standard Error 0.168
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Neutral Cues.040 beta weight (slope)Standard Error 0.207
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Neutral Cues-.243 beta weight (slope)Standard Error 0.192
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Reward Cues.255 beta weight (slope)Standard Error 0.247
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Reward Cues.679 beta weight (slope)Standard Error 0.267
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Reward Cues.745 beta weight (slope)Standard Error 0.226
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Neutral Cues.050 beta weight (slope)Standard Error 0.208
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Neutral Cues.493 beta weight (slope)Standard Error 0.181
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Neutral Cues-.123 beta weight (slope)Standard Error 0.224
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Reward Cues.511 beta weight (slope)Standard Error 0.257
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Reward Cues.310 beta weight (slope)Standard Error 0.267
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Reward Cues.079 beta weight (slope)Standard Error 0.257
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Neutral Cues-.370 beta weight (slope)Standard Error 0.208
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Reward Cues.419 beta weight (slope)Standard Error 0.226
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Neutral Cues.240 beta weight (slope)Standard Error 0.181
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Neutral Cues-.381 beta weight (slope)Standard Error 0.224
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Reward Cues.351 beta weight (slope)Standard Error 0.218
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Neutral Cues.047 beta weight (slope)Standard Error 0.17
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Neutral Cues-.111 beta weight (slope)Standard Error 0.183
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Reward Cues.403 beta weight (slope)Standard Error 0.209
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Neutral Cues.384 beta weight (slope)Standard Error 0.148
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Reward Cues.698 beta weight (slope)Standard Error 0.185
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Reward Cues.814 beta weight (slope)Standard Error 0.196
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Neutral Cues.621 beta weight (slope)Standard Error 0.157
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Neutral Cues.156 beta weight (slope)Standard Error 0.18
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Reward Cues.428 beta weight (slope)Standard Error 0.231
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Reward Cues.608 beta weight (slope)Standard Error 0.222
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Neutral Cues.140 beta weight (slope)Standard Error 0.194
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Neutral Cues.455 beta weight (slope)Standard Error 0.134
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Reward Cues.401 beta weight (slope)Standard Error 0.197
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Reward Cues.200 beta weight (slope)Standard Error 0.189
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Reward Cues.608 beta weight (slope)Standard Error 0.162
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Neutral Cues.016 beta weight (slope)Standard Error 0.165
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Neutral Cues.222 beta weight (slope)Standard Error 0.154
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Neutral Cues.518 beta weight (slope)Standard Error 0.134
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesPutamen Response to Reward Cues.663 beta weight (slope)Standard Error 0.167
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Neutral Cues.120 beta weight (slope)Standard Error 0.165
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesAccumbens Response to Reward Cues.480 beta weight (slope)Standard Error 0.197
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Reward Cues.468 beta weight (slope)Standard Error 0.189
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward CuesCaudate Response to Neutral Cues.185 beta weight (slope)Standard Error 0.154
Primary

Effects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward Feedback

This statistic shows the influence of major depressive disorder and childhood sexual abuse history on the strength of striatal activation (caudate, putamen, accumbens) in response to neutral and reward feedback during the monetary incentive delay task (MID). Striatal activation is measured using a statistic called a beta weight. A beta weight is a standardized regression coefficient. Higher beta weights mean greater striatal activation and lower beta weights mean less striatal activation. A negative beta weight would indicate a deactivation.

Time frame: 3 hour Session 2 (fMRI session)

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Neutral Feedback.010 beta weight (slope)Standard Error 0.308
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Reward Feedback-.101 beta weight (slope)Standard Error 0.329
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Neutral Feedback-.233 beta weight (slope)Standard Error 0.314
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Reward Feedback-.018 beta weight (slope)Standard Error 0.217
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Reward Feedback-.158 beta weight (slope)Standard Error 0.421
Control GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Neutral Feedback-.021 beta weight (slope)Standard Error 0.201
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Reward Feedback.063 beta weight (slope)Standard Error 0.26
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Reward Feedback.040 beta weight (slope)Standard Error 0.393
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Neutral Feedback-.418 beta weight (slope)Standard Error 0.24
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Neutral Feedback-.332 beta weight (slope)Standard Error 0.368
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Neutral Feedback-.608 beta weight (slope)Standard Error 0.376
MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Reward Feedback.839 beta weight (slope)Standard Error 0.503
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Reward Feedback-.046 beta weight (slope)Standard Error 0.544
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Reward Feedback-.087 beta weight (slope)Standard Error 0.281
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Neutral Feedback-.501 beta weight (slope)Standard Error 0.406
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Neutral Feedback-.142 beta weight (slope)Standard Error 0.26
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Neutral Feedback-.079 beta weight (slope)Standard Error 0.398
CSA/RES GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Reward Feedback-.197 beta weight (slope)Standard Error 0.425
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Reward Feedback-.713 beta weight (slope)Standard Error 0.544
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Reward Feedback-.905 beta weight (slope)Standard Error 0.425
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Neutral Feedback-.959 beta weight (slope)Standard Error 0.406
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Reward Feedback-.304 beta weight (slope)Standard Error 0.281
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Neutral Feedback-.276 beta weight (slope)Standard Error 0.26
CSA/MDD GroupEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Neutral Feedback-.819 beta weight (slope)Standard Error 0.398
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Reward Feedback-.554 beta weight (slope)Standard Error 0.444
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Neutral Feedback-.865 beta weight (slope)Standard Error 0.331
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Neutral Feedback-.456 beta weight (slope)Standard Error 0.325
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Reward Feedback-.819 beta weight (slope)Standard Error 0.347
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Neutral Feedback-.229 beta weight (slope)Standard Error 0.221
MDD-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Reward Feedback-.031 beta weight (slope)Standard Error 0.229
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Reward Feedback-.357 beta weight (slope)Standard Error 0.243
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Neutral Feedback-.108 beta weight (slope)Standard Error 0.225
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Neutral Feedback-.733 beta weight (slope)Standard Error 0.352
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Reward Feedback-.215 beta weight (slope)Standard Error 0.471
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Reward Feedback-.773 beta weight (slope)Standard Error 0.368
MDD-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Neutral Feedback-.039 beta weight (slope)Standard Error 0.345
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Neutral Feedback-.375 beta weight (slope)Standard Error 0.192
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Reward Feedback.074 beta weight (slope)Standard Error 0.401
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Reward Feedback-.613 beta weight (slope)Standard Error 0.314
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Reward Feedback-.533 beta weight (slope)Standard Error 0.207
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Neutral Feedback-.503 beta weight (slope)Standard Error 0.294
Control-amisulprideEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Neutral Feedback-.793 beta weight (slope)Standard Error 0.3
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Neutral Feedback.164 beta weight (slope)Standard Error 0.192
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackPutamen Response to Reward Feedback-.131 beta weight (slope)Standard Error 0.207
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Neutral Feedback.109 beta weight (slope)Standard Error 0.294
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackAccumbens Response to Reward Feedback.069 beta weight (slope)Standard Error 0.401
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Reward Feedback-.273 beta weight (slope)Standard Error 0.314
Control-placeboEffects on Major Depressive Disorder and Childhood Sexual Abuse History on Striatal Activity in Response to Neutral and Reward FeedbackCaudate Response to Neutral Feedback-.105 beta weight (slope)Standard Error 0.3
Primary

The Effect of Diagnosis on Cortisol Reactivity

This is a measure of area under the curve in relation to ground, a measure of total cortisol output, in response to acute stress. The acute stressor was the Maastricht Acute Stress Test (MAST). The area under the curve includes all 5 cortisol measures, with one measure before the stressor and the other four measures collected after the stressor. Given that the cortisol data were positively skewed, the cortisol measures were normalized via a log transformation prior to calculating the area under the curve. Area under the curve with respect to ground (AUCG) is calculated AUC\_g=(((cort2\_log + cort1\_log) \* cort\_t1\_time) / 2)+(((cort3\_log+cort2\_log)\*cort\_t2\_time)/2)+(((cort4\_log+cort3\_log)\*cort\_t3\_time)/2)+(((cort5\_log+cort4\_log)\*cort\_t4\_time)/2). Cort\_logs are the log transformed cortisol output data (ng/ml) and the cort\_times are the time spans in between each cortisol assessment.

Time frame: 3 hour EEG Session (Session 4)

ArmMeasureValue (MEAN)Dispersion
Control GroupThe Effect of Diagnosis on Cortisol Reactivity156.58 [log (ng/ml)]*minStandard Error 10.72
MDD GroupThe Effect of Diagnosis on Cortisol Reactivity186.78 [log (ng/ml)]*minStandard Error 12.2
CSA/RES GroupThe Effect of Diagnosis on Cortisol Reactivity152.13 [log (ng/ml)]*minStandard Error 12.2
CSA/MDD GroupThe Effect of Diagnosis on Cortisol Reactivity179.16 [log (ng/ml)]*minStandard Error 11.25
Primary

The Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under Stress

EEG was recorded during the probabilistic reward task (the PRT task). Participants completed the Probabilistic Reward Task (PRT) twice throughout the experiment, once before stress and once after stress. The stressor was the Maastricht Acute Stress Test (MAST). This statistic shows the effect that childhood sexual abuse (CSA) and diagnosis had on a reward-related positivity EEG component recorded during the PRT, before and after stress. * Higher reward positivity amplitudes indicate a stronger neural response to reward and lower amplitudes indicate a lower neural response to rewards.

Time frame: 3 hour EEG Session (Session 4)

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupThe Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under StressPre MAST2.71 amplitude (microvolts)Standard Error 0.86
Control GroupThe Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under StressPost MAST2.06 amplitude (microvolts)Standard Error 0.91
MDD GroupThe Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under StressPost MAST4.99 amplitude (microvolts)Standard Error 1.22
MDD GroupThe Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under StressPre MAST4.75 amplitude (microvolts)Standard Error 1.15
CSA/RES GroupThe Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under StressPre MAST2.16 amplitude (microvolts)Standard Error 0.92
CSA/RES GroupThe Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under StressPost MAST2.30 amplitude (microvolts)Standard Error 0.98
CSA/MDD GroupThe Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under StressPre MAST4.15 amplitude (microvolts)Standard Error 0.96
CSA/MDD GroupThe Effect of Major Depressive Disorder and Childhood Abuse History on a Reward-related EEG Component (Reward Positivity Component) While Under StressPost MAST3.90 amplitude (microvolts)Standard Error 1.01
Primary

The Effects of CSA and Diagnosis on PRT Performance Under Acute Stress

The participant's performance on the Probabilistic Reward Task (PRT) was assessed both before and after an acute stressor. The PRT is a behavioral task that measures an individual's ability to learn from rewarding stimuli and incorporate this learning into their response style (response bias). The acute stressor was the Maastricht Acute Stress Test (MAST). The score obtained is a ratio of the number of times participants correctly choose the high reward stimuli versus the low rewarding stimuli. Response bias scores range between -1 and +1. Higher response bias scores indicate a stronger response bias toward high reward stimuli. A negative response bias indicates a stronger bias toward low reward stimuli.

Time frame: 3 hour EEG Session (Session 4)

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block1: Before MAST0.028 Ratio (Response Bias Score)Standard Deviation 0.035
Control GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block2: Before MAST0.124 Ratio (Response Bias Score)Standard Deviation 0.046
Control GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block1: After MAST0.128 Ratio (Response Bias Score)Standard Deviation 0.026
Control GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block2: After MAST0.245 Ratio (Response Bias Score)Standard Deviation 0.041
MDD GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block2: Before MAST0.155 Ratio (Response Bias Score)Standard Deviation 0.048
MDD GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block1: After MAST0.078 Ratio (Response Bias Score)Standard Deviation 0.055
MDD GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block2: After MAST0.128 Ratio (Response Bias Score)Standard Deviation 0.035
MDD GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block1: Before MAST0.117 Ratio (Response Bias Score)Standard Deviation 0.045
CSA/RES GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block1: After MAST0.079 Ratio (Response Bias Score)Standard Deviation 0.042
CSA/RES GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block2: Before MAST0.130 Ratio (Response Bias Score)Standard Deviation 0.082
CSA/RES GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block2: After MAST0.143 Ratio (Response Bias Score)Standard Deviation 0.052
CSA/RES GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block1: Before MAST0.092 Ratio (Response Bias Score)Standard Deviation 0.043
CSA/MDD GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block2: After MAST0.127 Ratio (Response Bias Score)Standard Deviation 0.05
CSA/MDD GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block2: Before MAST0.168 Ratio (Response Bias Score)Standard Deviation 0.102
CSA/MDD GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block1: Before MAST0.167 Ratio (Response Bias Score)Standard Deviation 0.07
CSA/MDD GroupThe Effects of CSA and Diagnosis on PRT Performance Under Acute StressPRT Block1: After MAST0.048 Ratio (Response Bias Score)Standard Deviation 0.042

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026